Pliant Therapeutics
(NASDAQ) PLRX
Pliant Therapeutics Financials at a Glance
Market Cap
$81.73M
Revenue (TTM)
$0.00
Net Income (TTM)
$149.34M
EPS (TTM)
$-2.43
P/E Ratio
-0.54
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$1.35
Volume
521,597.459
Open
$1.30
Price
$1.35
Volume
521,597.459
Open
$1.30
Previous Close
$1.32
Daily Range
$1.28 - $1.38
52-Week Range
$1.09 - $1.95
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$1.35
Volume
521,597.459
Open
$1.30
Previous Close
$1.32
Daily Range
$1.28 - $1.38
52-Week Range
$1.09 - $1.95
PLRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pliant Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
49
CEO
Bernard Coulie, MD, PhD
Website
www.pliantrx.comHeadquarters
South San Francisco, CA 94080, US
PLRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-62%
Return on Capital
-74%
Return on Assets
-66%
Earnings Yield
-1.85%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$81.73M
Shares Outstanding
61.91M
Volume
521.60K
Short Interest
0.00%
Avg. Volume
778.00K
Financials (TTM)
Gross Profit
$1.70M
Operating Income
$150.07M
EBITDA
$148.38M
Operating Cash Flow
$128.34M
Capital Expenditure
$374.00K
Free Cash Flow
$128.71M
Cash & ST Invst.
$190.94M
Total Debt
$29.11M
Pliant Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$365.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$81.73M
N/A
Market Cap/Employee
$477.94K
N/A
Employees
171
N/A
Net Income
$23.58M
+52.6%
EBITDA
$28.33M
+41.5%
Quarterly Fundamentals
Net Cash
$161.84M
-45.2%
Accounts Receivable
$823.00K
-64.2%
Inventory
$0.00
N/A
Long Term Debt
$55.32M
-7.3%
Short Term Debt
$1.45M
+167.0%
Return on Assets
-66.31%
N/A
Return on Invested Capital
-73.67%
N/A
Free Cash Flow
$17.79M
+62.8%
Operating Cash Flow
$17.79M
+62.7%